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Abstract
While histopathology of excised tissue remains the gold standard for diagnosis, several new, non-invasive
diagnostic techniques are being developed. They rely on physical and biochemical changes that precede and
mirror malignant change within tissue. The basic principle involves simple optical techniques of tissue
interrogation. Their accuracy, expressed as sensitivity and specificity, are reported in a number of studies suggests
that they have a potential for cost effective, real-time, in situ diagnosis.
We review the Third Scientific Meeting of the Head and Neck Optical Diagnostics Society held in Congress
Innsbruck, Innsbruck, Austria on the 11th May 2011. For the first time the HNODS Annual Scientific Meeting was
held in association with the International Photodynamic Association (IPA) and the European Platform for
Photodynamic Medicine (EPPM). The aim was to enhance the interdisciplinary aspects of optical diagnostics and
other photodynamic applications. The meeting included 2 sections: oral communication sessions running in
parallel to the IPA programme and poster presentation sessions combined with the IPA and EPPM posters sessions.
Introduction
The anatomy of the head and neck is unique and com-
plex. However, since the oral cavity and the aero-digestive
tracts are easily accessible to direct examination it is fea-
sible that disease process can be detected at an early
stage. Nevertheless, in as many as 40% of patients, the
disease at presentation is already at an advanced stage
(T3/T4). This is unfortunate, since, the diagnosis and
management of dysplastic changes or frank malignancy at
an early stage would result in favourable outcome for
majority of these patients [1,2]. The outlook will improve
even further if simple techniques were available for sur-
veillance and early detection of malignant transformation,
and, recurrence following management. It will have a
positive impact not only on improving the survival rate,
but also preservation of function with low morbidity and
better quality of life.
Successful management of early lesions encompasses
continuous monitoring for detection of recurrence.
Although the standard approach is by clinical examina-
tion with surgical biopsies, the optimum conditions for
effective follow-up are not always available. The Inade-
quacy of documentation and imaging, relative inexperi-
ence of trainee grades, and the ever increasing clinical
workload which is matched only by sparse funding are
some of the factors which influence assessment for
regression or progression. The implementation of “diag-
nostic aids” can help bridge this gap. A reliable, user-
friendly and less skill-dependent technique will take away
the multivariate factors which currently determine the
quality of monitoring. These methods help reduce uncer-
tainty and help guide the clinician to a diagnosis reducing
waiting times and hopefully improving outcomes.
The optical diagnostic aid provides a non-invasive and
real-time diagnosis. Several aids are already in use,
* Correspondence: waseem_wk1@yahoo.co.uk
1The “Head and Neck Optical Diagnostics Society” Council, The International
Society of Minimally Invasive Diagnostics, University College London,
London, UK
Full list of author information is available at the end of the article
Jerjes et al. Head & Neck Oncology 2011, 3:38
http://www.headandneckoncology.org/content/3/1/38
© 2011 Jerjes et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
including brush biopsy, vital staining, molecular mar-
kers, cytology and chemiluminescence [3]. However
several factors limit their availability and interpretation
of the results requires highly trained personnel.
1. What is optical diagnostics?
Optical diagnostics ‘biopsy’ (optical biopsy) involves the
use of light of varying wavelength to examine the suspect
tissue. The optical diagnostic methods are not aimed at
differentiating between normal and abnormal tissue, since
this can easily be achieved by direct or endoscopic visuali-
sation. Optical diagnosis aims to provide differentiation of
areas of similar clinical characteristics, i.e. dysplasia vs. car-
cinoma in situ [4-7]. Optical biopsy interrogates areas of
pathology such as hyperkeratosis, inflammation, dysplasia,
carcinoma in situ and neoplasia. Of course the technique
should be minimally invasive and provide diagnosis in real
time and in vivo. There are a number of “in vitro” and
‘immediate “ex vivo” modalities in common use and they
include: elastic scattering spectroscopy, deferential path-
length spectroscopy, near infrared spectroscopy, Raman
spectroscopy, confocal spectroscopy, fluorescence imaging,
microendoscopy, and optical coherence tomography.
2. Elastic Scattering Spectroscopy (ESS)
Exposure of tissue to light results in a series of absorption
and scattering events. The light beam undergoes single or
multiple elastic scattering which implies that the light
returns with the same energy as the incident photons. The
extent of scattering effect depends on the relationship
between the light wavelength and the particulate size.
A scattering event carries with it all the characteristics
of the cellular components, which are called ‘scattering
centres.’ These centres can be normal or pathological.
Normal centres are nucleus, nucleolus, chromatin con-
tent and metabolic organelles. Pathological centres may
be in the form of disorganized epithelial orientation and
architecture, changes in morphology of epithelial surface
texture and thickness, cell crowding, increased distance
from sub-epithelial collagen layer, enlargement and
hyperchromicity of cell nucleus, increased concentration
of metabolic organelles and presence of abnormal protein
packages or particles.
These cellular and sub-cellular changes are identified by
using the refractive indices of the cellular components.
The resultant scattered light (elastic light scattering pro-
cess) is then collected and analysed by a spectrometer and
a spectrum is generated [8-10].
The light emitted by cellular and sub-cellular orga-
nelles ranges from 330 nm to 850 nm, which is within
the near UV and visible part of the spectrum. The ESS
system is thus designed to cover a range of 300 - 900 nm
and consists of a pulsed xenon arc lamp for the light
source, a PC compatible spectrometer, an optical fibre
(graded-index) based probe, and a laptop computer for
system control and data display.
The system has a fibre-optic probe which incorporates
two optical fibres, one to transmit the light into the tissue
and the other for collecting scattered light. The tip of
the probe is momentarily placed in direct contact with the
suspected lesion and activated at the keyboard or by the
foot pedal. The system takes a background measurement
before firing the lamp. This is followed immediately
(within-100 ms) by an ESS measurement with the pulsed
lamp. The background spectrum is then subtracted from
the ESS spectrum. The entire measurement processing
display takes less than 1 second.
The clinical application of this emerging modality in
the head and neck is still limited. Three studies carried
out at the UCLH Head and Neck Centre, London,
showed promising results on metastatic cervical lymph
nodes (immediate ex vivo), cancerous bony mandible
(archived, in vitro) and dysplastic oral lesions (in vivo).
A sensitivity and specificity indices were 98% and 68%
for lymph nodes, 87% and 80% for mandible, and 72%
and 75% for dysplastic oral lesions, [8-10]. In a recent in
vivo study (unpublished data) differing optical spectra
(signatures) were obtained specifically with basal cell
carcinoma, seborrhic keratosis, fibroepithelial polyp and
intradermal nevi from 73 patients with suspicious head
and neck skin lesions. These spectral allowed the accu-
rate differentiation of these benign and malignant
lesions with a high degree of accuracy.
Muller et al [11] used ESS to compare data from nor-
mal and abnormal tissue in the oral cavity. Using histo-
pathology as control, the accuracy for spectroscopy for
normal was 91.6% and for abnormal, 97%. An in vivo
study was carried out at the National Medical Laser
Centre, London to detect high grade dysplasia and can-
cer, and differentiate it from inflammation in Barrett’s
oesophagus. The results showed 92% sensitivity and 60%
specificity in detecting high grade dysplasia or cancer.
The differentiation from inflammatory lesion showed
sensitivity and specificity of 79% [12].
ESS requires a close collaboration between clinicians and
physicists to cleanse and normalise the obtained spectra
and interpret the algorithms. Statistical support can be dif-
ficult and time consuming. Co-registration can be a pro-
blem since optical signature reports pathology changes
from just 1 mm3 area. Therefore, with inherent 30%
shrinkage due to formalin, multiple areas need to be inter-
rogated and then compared with the ‘gold standard’ histo-
pathology. Detection of cancer in as small an area as
1 mm3 would indicate a definitive treatment strategy. The
drawback is lack of tumour margin detection which would
entail treating much larger area than that detected posi-
tively. The advantage of the technique is the objective auto-
mated interpretation reducing user error and steepening
Jerjes et al. Head & Neck Oncology 2011, 3:38
http://www.headandneckoncology.org/content/3/1/38
Page 2 of 8
the learning curve of the operator. It also allows good qual-
ity control.
3. Differential Path-length Spectroscopy (DPS)
Differential Path-length Spectroscopy is a minimally
invasive technique able to determine intrinsic in vivo
optical properties. This technology was developed at the
Erasmus Medical Centre, Rotterdam. DPS is considered
to be a form of elastic scattering spectroscopy but with
fixed photon pathlength, fixed photon visitation depth
and absolute measurement of absorbers [13]. Optical
pathlength of photons is constant within reasonable
range of optical properties. The signal combines informa-
tion about intracellular morphology, cell biochemistry
(bilirubin/betacarothene) and microvascular properties
(oxygen saturation and average vessel diameter).
The system is a fibre-based diffuse reflection spectro-
meter with a tungsten-halogen lamp as a white light
source. The first spectrometer uses a bifurcated fibre for
illumination and collection. A second fibre carries diffusely
reflected light to a second spectrometer. Each spectro-
meter records a spectrum with a slightly different wave-
length scale. Subtraction of two measurements selects
superficially scattered light.
DPS was used to determine the superficial optical prop-
erties of oral mucosa in vivo [14], bronchial tree [15] and
breast tissue in vivo [16]. These studies showed that the
malignant tissue at these sites was characterised by a sig-
nificant decrease in micro-vascular oxygenation, higher
blood content, significant decrease in scattering amplitude
and increase in scattering slope, as compared to the nor-
mal tissue.
4. Near infrared spectroscopy
Near infrared (NIR) spectrum (800-2500 nm) is cur-
rently being used in medical diagnostics, pharmaceuti-
cals and combustion research. Absorption and
transmission of NIR light in biological tissue provides
information about haemoglobin concentration (i.e. oxy-
and deoxy-hemoglobin) [7]. Although NIR light pene-
trates further into tissue compared to other modalities,
molecular absorption is quite small and therefore, sensi-
tivity is not high. Since the spectra generated from the
near infra-red region depend on molecular overtone and
combination vibrations, complex spectra thus generated
are hard to analyse.
The potential role of infrared spectroscopy in biome-
dical science has been proposed to distinguish different
biomolecules by probing chemical bond vibrations and
using these molecular and sub-molecular patterns to
define and differentiate pathological from healthy sam-
ples as well as distinguishing various kinds and grades
of neoplasia in human tissues [17].
5. Raman spectroscopy
Raman spectroscopy is used in physics and chemistry to
study vibrational and other low-frequency modes in a
system, enabling chemical characterisation and structure
of molecules in a sample. It relies on inelastic scattering
(loss or gain of energy) of monochromatic light, usually
from a laser in the visible, near infrared or near ultravio-
let range. The laser light interacts with molecular vibra-
tions, resulting in the energy of the laser photons being
shifted up or down. The shift in energy gives informa-
tion about the photon modes in the system. Raman
spectroscopy is being considered as complementary or
even as an alternative technique for biopsy, pathology
and clinical assays in many medical technologies [7,18].
Raman bands, due to biological constitutes, are gener-
ally overlapped (Raman effect), making it difficult to
identify individual components correctly. Furthermore,
due to the minimal sample preparation encountered in
the clinical environment, biomedical samples tend to
produce a strong fluorescent background which may
completely obscure the true Raman signals.
Although Raman spectroscopy has been investigated for
several decades, clinical studies in head and neck area are
scant. In oncology, Raman spectroscopy is being investi-
gated as a diagnostic tool for characterising early malig-
nant changes. Using human tissues, researchers from
University Hospital, Groningen, reported a study involving
37 human oral mucosa lesions, showing clear variations
between different cell layers (keratin/epithelium versus
connective tissue layer), [19]. Raman spectroscopy is a
highly sensitive and specific technique for demonstration
of biochemical changes in the carcinogenesis of Barrett’s
oesophagus. Biophotonics Research Group at the Glouces-
tershire Royal Hospital reported several techniques to
diagnose oesophageal adenocarcinoma at an earlier stage
[20].
Forty blood samples were obtained from patients with
head and neck cancer and patients with respiratory ill-
nesses, who acted as controls. Raman spectroscopy was
carried out on all samples with the resulting spectra
being used to build a classifier in order to distinguish
between the cancer and respiratory patients’ spectra. A
preliminary study demonstrated the feasibility of using
Raman spectroscopy in cancer screening and diagnostics
of solid tumours through a peripheral blood sample
[21]. Neural network analysis applied in the discrimina-
tion of human thyroid cell lines provided 95% accuracy
for identification of cancerous cell lines and 92% accu-
racy for normal cell line [22]. Detection sensitivity for
parathyroid adenomas was 95% and hyperplasia was
93% [23].
The signal generated by Raman scattering is very weak
and pose a diagnostic difficulty. Preliminary studies are
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very encouraging. Diagnostic accuracy can be comple-
mented by combining this technology with infra or near
infrared spectroscopy.
6. Confocal reflectance microscopy (CRM)
Confocal reflectance microscopy (CRM) is a non-invasive
imaging tool enabling “optical biopsies” of tissues at cel-
lular level. CRM differs from a conventional microscopy
in that it uses a point source of light, typically a laser, to
illuminate a small spot within tissue. Backscattered (or
reflected) light from the tissue is captured through an
aperture, which matches the size of the illuminated spot
placed in front of the detector. The aperture spatially fil-
ters light returning from out-of-focus planes within the
tissue, imaging only the plane in focus. The gray-scale
image created is an optical section representing one focal
plane within the examined specimen.
This technique can supply detailed information of the
epithelium 0.1-0.5 mm in depth. Since the 1980s, several
investigators have shown the utility of confocal micro-
scopy for imaging human and animal tissues in vivo [24].
More recently, confocal imaging has shown stronger dif-
ferentiation between nuclear and dermal contrast and
improved detection of tumours. By using a contrast agent,
confocal images may be collected specifically from nuclear
structures with very little interference from the surround-
ing dermis, resulting in 1000-fold improvement in
nuclear-to-dermal contrast [25].
Confocal microscopy has demonstrated to date the most
clinical utility in ophthalmology, where it has been used to
image the cornea [26,27]. Intravenous fluorescein is used
for angiography or angioscopy of the retina and iris vascu-
lature. After injection, fluorescein binds extensively to
serum albumin in the bloodstream. The unbound contrast
diffuses across capillaries, entering the tissue and staining
the extracellular matrix of the surface epithelium and the
lamina propria for up to 30 mins [28]. Cell nuclei and
mucin are not stained by fluorescein and therefore appear
dark. The mucosal structures that can be identified after
fluorescein administration include enterocytes, cellular
infiltrate, surface epithelial cells, blood vessels, and red
blood cells.
Confocal microscopy has been used for identifying in
vivo cellular and intracellular changes in oropharyngeal
epithelia. The most limiting factors for confocal micro-
scopic investigation are the presence of severe hyper- and
parakeratosis and extensive hyperplasia of the laryngeal
epithelium in macroscopic leukoplakia. The failure of
illumination of the tissue results from the higher refrac-
tive index of keratin in comparison with cytoplasm [29].
7. Fluorescence Imaging
All tissues fluoresce due to the presence of fluorescent
chromophores (fluorophores) within them. The
fluorescence can either occur as autofluoresence (if
induced by UV light), or as a laser-induced phenomenon
enhanced by either topical or systemic application of 5-
aminolaevulinic acid (ALA). Fluorescence spectroscopy
can detect these substances and provide characteristic
spectra that reflect biochemical changes occurring within
the tissue [6,7]. Commercially available fluorescence ima-
ging equipment aims at highlighting malignant tissue,
especially where it is not evident under white light in a
large field of view.
An optical endoscope can be used for both illumina-
tion and detection of the tissue fluorescence. The
images are captured by a frame-grabber fitted with an
analogue/digital converter (ADC) and analysed and dis-
played on a personal computer supplied with the appro-
priate software. At the Ludwig Maximilian University,
Munich, a great deal of work has been undertaken using
autofluorescence laryngoscopy, and 5-ALA laryngoscopy.
In a prospective study [30], both autofluorescence laryn-
goscopy, and 5-ALA laryngoscopy was undertaken in 56
patients with precancerous and cancerous lesions of the
cord. They reported the following results: during auto-
fluorescence endoscopy, normal laryngeal mucosa pre-
sented a typical green fluorescence signal in, which
turned blue during 5-ALA-laryngoscopy, both imaging
techniques were suitable to distinguish benign from pre-
cancerous or cancerous lesions. Fluorescence was absent
during autofluorescence endoscopy for precancerous
and cancerous lesions, whereas increased protopor-
phyrin IX fluorescence (PPIX) was noted during 5-ALA
laryngoscopy. PPIX fluorescence was easily recognized
in scarred vocal folds. Both autofluorescence and 5 ALA
induced PPIX imaging techniques are useful in the early
diagnosis of laryngeal cancer. Moreover autofluores-
cence can be used immediately without drug application
and possible side effects. 5-ALA-induced fluorescence
seems to be more suited for diagnostic examination of
mucosal lesions in recurrent precancerous and cancer-
ous lesions after surgery.
Several studies at the MD Anderson Cancer Center,
Houston found differences in spectra from normal, dysplas-
tic, and malignant oral mucosa [31,32]. At UCLH Head and
Neck Centre, London a study was undertaken for fluores-
cence imaging with the topical application of 5-aminolevu-
linic as mouth rinse in 71 patients who presented with
clinically suspicious oral leukoplakia. A sensitivity of 83-
90% and specificity of 79-89% were obtained between nor-
mal and dysplastic lesions [33]. University Hospital Gronin-
gen researchers recorded autofluorescence spectra from 96
volunteers with no clinically observable oral lesions. Skin
colour strongly affected autofluorescence intensity. Gender
differences were found in blood absorption. Alcohol
consumption was associated with porphyrin-like peaks.
However, all differences apart from those associated with
Jerjes et al. Head & Neck Oncology 2011, 3:38
http://www.headandneckoncology.org/content/3/1/38
Page 4 of 8
skin colour were of the same order of magnitude as stan-
dard deviations within categories [34].
8. Microendoscopy
Microendoscopy involves examining tissue in situ at a
magnification from 60× to 1000×. At this magnification,
details of tissues, cells and cellular ultra-structures can be
also observed to detect specific patterns for pathology,
i.e. inflammation, metaplasia, dysplasia, and malignancy.
The Storz Hopkins II auto-clavable microendoscope is
attached to a camera system linked via a video recorder
with outputs to a monitor and photo-printer. The scope
is available in different sizes which can be used for differ-
ent anatomical sites; the dimensions of the microendo-
scope are 5.5 mm diameter and 23 cm long, the vital
stain Methylene blue is used.
Unlike frozen section biopsy, the microendoscope pro-
vides a real time magnification at examination and can
be used to guide further surgery, biopsy or simple surveil-
lance of large areas of suspect mucosa. A recent study at
Rice University, Houston evaluated microendoscopic
imaging to identify neoplastic lesions in patients with
Barrett’s esophagus. Subjective analysis of the images by
expert clinicians achieved average sensitivity and specifi-
city of 87% and 61%, respectively [35]. The main applica-
tion with the scope is that we can have a more informed
assessment of the state of the in situ epithelial margin
when excising squamous cell carcinoma. Combined with
the recent advance of vital or immunologically tagged
antibody targeted staining, microendoscopy will enable
histopathological assessment of the surgical margin as
against the standard clinically assessed margin. The
extension of this technology to the management of glottic
cancer will obviously have a great impact for the preser-
vation of the voice quality with ‘endoscopically assessed’
clear histological margin in real time. As with all image
based or image enhanced technologies there are issues
with interpretation and user learning curves to ensure
consistent quality control and results.
9. Optical Coherence Tomography
Optical coherence tomography (OCT) uses light to deter-
mine cross-sectional anatomy in turbid media such as liv-
ing tissues. OCT is analogous to ultrasound imaging
except that it uses light rather than sound. The high spa-
tial resolution of OCT enables non-invasive in vivo “opti-
cal biopsy” and provides immediate and localized
diagnostic information [36]. OCT images are formed by
dividing light from an optical source into two paths, one
of which is directed to the tissue sample, and the other to
a reference mirror. Light reflected from the sample is
recombined with light from the reference mirror and
detected, forming an interference signal only when the
lengths of the sample and reference paths are matched to
within a short distance termed the coherence length of
the light source.
OCT has been applied in the head & neck, especially
in the nasopharynx, oropharynx, and larynx in an
attempt to detect areas of inflammation, dysplasia and
cancer. The Beckman Laser Institute and Medical Clinic,
University of California Irvine, Irvine undertook clinical
studies in laryngeal pathology. OCT was coupled to a
surgical microscope, allowing hands-free OCT simulta-
neously with visualization of the vocal cords [37,38] to
distinguish benign lesions from microinvasive cancer
that has violated the integrity of the basement mem-
brane (BM) [39]. This technology has yet to deliver the
promise of the recognition of basement membrane to
detect its invasion by malignancy.
OCT has been used at the University College Hospital,
London, in 27 patients with suspicious oral lesions to
assess changes in keratin, epithelial, sub-epithelial layers
and identification of the basement membrane in patients.
The acquired OCT data were then compared with histo-
pathology results. This pilot study confirmed the feasibil-
ity of using OCT to identify architectural changes in
pathological tissues [40]. The main issues lie around
image quality and ‘histological’ interpretation. Further
unpublished data indicates the feasibility of OCT in
assessing oral and skin resection margins in clinical set-
ting in the very near future.
10. The Meeting
The aims and objectives were introduced by the Chair-
man, Mr Colin Hopper, in his opening address. The
Chairman gave an overview on optical diagnostics and dis-
cussed the challenges in the field of optical diagnostics
that suffers from shortages in clinical academics as well as
funding. The overall conclusion was that the Society is
growing and becoming known worldwide and have a great
wealth in its members of clinical academics and scientists.
This society will continue to dedicate itself to helping
develop optical diagnostic techniques in the head and
neck and provide training networks for the exchange of
information and education. The Officers noted that the
attendance to the meeting was less than expected.
However, it was very encouraging to see many senior fig-
ures from the world of optical diagnostics, from North
America and many of the established universities through-
out Europe.
The Programme Committee included Colin Hopper,
University College London, United Kingdom, Henricus
J.C.M. Sterenborg, Erasmus Medical Centre, The Neth-
erlands, Waseem K. Jerjes, UCL Medical School, Uni-
ted Kingdom, Adel K El-Naggar, The University of
Texas M.D. Anderson Cancer Center, USA, Brian J.F.
Wong, University of California Irvine, USA, Max J.H.
Witjes, University Medical Center Groningen, The
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Netherlands and Tahwinder Upile, Barnet & Chase
Farm Hospitals NHS Trust, United Kingdom.
The theme was set by the first presentation by Wong
B. He highlighted the experience of the Beckman Laser
Institute and Medical Clinic, University of California
Irvine with regards to the use of optical coherence
tomography. The results from this comprehensive pre-
sentation showed that enormous success achieved in the
dynamic imaging of the larynx using optical coherence
tomography. One particular interesting field was moni-
toring of the local tissue injury and stenosis in neonates.
This was followed by a series of interesting lectures by
Kowalski C on longitudinal oral mucosal tissue imaging
using co-localised optical coherence tomography and
micro-vascular imaging and Hamdoon Z on optical
coherence tomography of the tongue papillae for
patients suffering from taste disorders following che-
moradiotherapy and risk assessment of oral epithelium
thickness using in vivo OCT. Witjes M discussed the
use of optical coherence tomography for classification of
oral mucosal lesions as well as the Netherlands experi-
ence when it comes to this technology. The 1st session
completed by a very interesting lecture by Ilgner J from
Aachen University Hospital on OCT imaging in middle
ear diagnostics.
The second session was highlighted by 3 lectures by
Jerjes W on the clinical applications of elastic scattering
spectroscopy in head and neck, Witjes M on single fiber
reflectance measurements of cervical lymph nodes for
identifying metastasis from oral carcinoma and a very
interesting lecture by Cook R on micro-vascularoscopy
and discussed its applications as a valuable technique for
localised optical tissue assessment. The theme of the last
session was on the use of optical technology to guide and
monitor treatment. The lectures included discussions on
the in vivo quantification of photosensitizer concentration
using optical spectroscopy, non-invasive monitoring of
photodynamic therapy of oral cancers by fluorescence dif-
ferential path-length spectroscopy, determination of tissue
optical properties in ALA-mediated head & neck PDT,
monitoring photodynamic therapy using quantitative
reflectance and fluorescence spectroscopic measurements,
optical coherence tomography-guided photodynamic ther-
apy for skin cancer, fluorescence spectroscopy during
ALA/PpIX-mediated PDT of the oral cavity and treatment
planning for interstitial photodynamic therapy of head and
neck cancer.
HNODS Elections 2011
The Nomination Committee included the following
members: Christian S Betz, Alexander J MacRobert,
Malini Olivo, Henricus JCM Sterenborg and Brian JF
Wong. Forms to nominate members for election as
Officers and Councillors has been sent to Council Mem-
bers. It was decided that no elections to take place as
there was only one candidate for Chairmanship.
The results for were announced at the end of
HNODS Annual Meeting in May 2011. The Chairman
from September 2011 will be Brian JF Wong and the
Society’s other Officers include Christian S Betz,
Tahwinder Upile, Henricus JCM Sterenborg and Kris-
tian Berg. The Society will be supported by 5 Council-
lors including Merrill A Biel, Adel K El-Naggar,
Dominic J Robinson, Jennifer Rosen and Arjun G Yodh.
The Immediate Past Chairman for 1 year will be Colin
Hopper. The HNODS Council welcomed Dr Jennifer
Rosen and Dr Arjen Amelink as new Council Members.
11. Discussion
Optical diagnostics provides non-invasive techniques that
will allow improved surgical decision making with better
appreciation by the clinician of the histopathological nat-
ural history of the disease. These novel technologies will
also drive improved image and evidence based medical
education with better documentation and audit, allowing
informed clinical choices whilst operating. It would also
facilitate targeted training and education in their usage
and dissemination of its applications to virtually any dis-
cipline in medicine, surgery or dental practice.
Benefits to the patients are evident. Rather than having
all suspicious areas excised for histopathological confir-
mation, only those areas which are optically proven to be
suspicious will be biopsied. This will lead to reduced
workload for the labs and there will be an increased posi-
tive yield, with significant resource implications.
Optically-directed excision may allow more complete
disease treatment thus reducing the rate of recurrent or
residual disease. The costs of a failed surgical margin
are considerable in terms of increased morbidity and
mortality with a halving of patients’ survival, resulting in
increased costs of adjuvant therapies and major revision
surgery.
We anticipate the future publication of libraries of nor-
mative and pathological data to act as a standard clinical
reference. This will enable the practitioner to use these
validated technologies to help them in their day-to-day
clinical work. We would predict that the practitioner
would eventually be able to determine the diagnosis
immediately by looking at the image on the screen. The
technologies would, for a small initial outlay, provide the
means to accurately diagnose a range of benign, malignant
and infective conditions.
12. Conclusions
Optical diagnosis of the head and neck is a rapidly
developing area of clinical research that can be readily
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translated to enhance patient treatment and overall
quality of life. Much still needs to be achieved and
granting organisations are solicited to pay attention to
this specialty where relatively small investments may
lead to enormous dividends in terms of improvements
in treatments throughout the fields of medicine and sur-
gery and dentistry.
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